2021-01-11,Rubius Therapeutics Provides Operational Update and Outlines 2021 Objectives  at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-04,Rubius Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
2020-12-10,Is Rubius (RUBY) A Good Stock To Buy Now?
2020-11-30,Rubius Therapeutics to Participate in Evercore ISI 3rd Annual HealthCONx Conference
2020-11-10,Rubius Therapeutics to Participate in Jefferies Virtual London Healthcare Conference
2020-11-09,Rubius Therapeutics Reports Third Quarter 2020 Financial Results and Strong Execution Across the Pipeline
2020-11-09,"Rubius Therapeutics Presents Preclinical Data for Lead Red Cell Therapeutic Clinical Oncology Program, RTX-240, at the Society for Immunotherapy of Cancers Annual Meeting"
2020-11-05,Rubius Therapeutics Announces Dosing of First Patient with Relapsed/Refractory Acute Myeloid Leukemia in the Ongoing Phase 1/2 Clinical Trial of  RTX-240
2020-10-29,Rubius Therapeutics to Announce Third Quarter 2020 Financial Results
2020-10-28,"Rubius Therapeutics Presents Preclinical Data for RTX-321, a Red Cell Therapeutic Oncology Product Candidate for HPV-Positive Cancers, Demonstrating its Dual Mechanism of Action"
2020-10-15,"Rubius Therapeutics Announces Preclinical Data Supporting its Lead Clinical Oncology Program, RTX-240, to be Presented at the Society for Immunotherapy of Cancers Annual Meeting"
2020-10-13,"Are Insiders Buying Rubius Therapeutics, Inc. (NASDAQ:RUBY) Stock?"
2020-09-29,Rubius Therapeutics to Participate in 7th Annual Jefferies Cell Therapy Summit
2020-09-28,Rubius Therapeutics Appoints Jose Carmona as Chief Financial Officer
2020-09-22,"3 High-Risk, High-Reward Stocks to Add to Your Watch List"
2020-09-08,Rubius Therapeutics to Participate at Upcoming Investor Conferences
2020-08-10,Rubius Therapeutics Reports Second Quarter 2020 Financial Results and Positive Progress Across Pipeline
2020-08-03,Rubius Therapeutics to Announce Second Quarter 2020 Financial Results
2020-07-07,Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing
2020-06-30,Rubius Therapeutics Provides Update on Clinical Trial Progress for its Lead Oncology Product Candidate RTX-240 and Announces Planned Leadership Transition
2020-06-22,"Rubius Therapeutics Highlights Preclinical Data for RTX-321, a Red Cell Therapeutic Oncology Product Candidate for HPV-Positive Cancers, at the American Association of Cancer Research Virtual Annual Meeting II"
2020-06-01,"Hedge Funds Are Selling Rubius Therapeutics, Inc. (RUBY)"
2020-05-28,Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity
2020-05-26,Rubius Therapeutics to Present at Jefferies Virtual 2020 Healthcare Conference
2020-05-15,"Rubius Therapeutics to Present Preclinical Data for RTX-321, a Red Cell Therapeutic Oncology Product Candidate for HPV-Positive Cancers at the American Association of Cancer Research Annual Meeting"
2020-05-12,"Rubius Therapeutics Highlights Preclinical Data for RTX-321, a Red Cell Therapeutic Oncology Product Candidate for HPV-Positive Cancers, at the American Society of Gene & Cell Therapy 23rd Annual Meeting"
2020-05-11,Rubius Therapeutics Reports First Quarter 2020 Financial Results and Provides Operational Update
2020-05-07,"Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial of RTX-240, an Allogeneic Cellular Therapy, for the Treatment of Solid Tumors"
2020-05-04,Rubius Therapeutics to Announce First Quarter 2020 Financial Results
2020-04-29,Rubius Therapeutics Announces Preclinical Data from Red Cell Therapeutic Oncology Programs to be Presented at the ASGCT 23rd Annual Meeting
2020-04-16,"CEO, President & Director Pablo Cagnoni Just Bought A Handful Of Shares In Rubius Therapeutics, Inc. (NASDAQ:RUBY)"
2020-03-12,Rubius Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Announces Strategic Focus on Oncology and Autoimmunity
2020-03-03,Rubius Therapeutics to Report Fourth Quarter and Full-Year 2019 Financial Results and Host Webcast
2020-01-30,Rubius Therapeutics Announces First Patient Dosed in Phase 1b Trial of RTX-134 for the Treatment of Patients with Phenylketonuria
2020-01-14,BioMarin to Begin Early-Stage Study on Gene Therapy for PKU
2020-01-13,"'We will deliver in 2020,' Cambridge biotech CEO promises after 2nd trial disappointment"
2020-01-13,Rubius Therapeutics Announces 2020 Objectives and Provides Operational Update at the 38th Annual J.P. Morgan Healthcare Conference
2020-01-08,"Rubius Therapeutics Appoints Internationally Recognized Autoimmunity and Translational Immunology Leader Laurence Turka, M.D., as Chief Scientific Officer"
2020-01-02,Rubius Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-23,"Rubius Therapeutics Appoints Christina Coughlin, M.D., Ph.D., as Chief Medical Officer"
2019-12-21,"Rubius Therapeutics, Inc. (RUBY): Are Hedge Funds Right About This Stock?"
2019-12-19,Flagship Unveils Newest Pioneering Platform: Ring Therapeutics
2019-12-18,"Rubius Therapeutics Appoints Anne Prener, M.D., Ph.D., to its Board of Directors"
2019-11-14,Rubius Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress
2019-11-12,Rubius Therapeutics to Participate in Jefferies London Healthcare Conference
2019-11-12,Rubius Therapeutics Appoints Maiken Keson-Brookes as Chief Legal Officer and Corporate Secretary
2019-11-08,Rubius Therapeutics Highlights Preclinical Oncology Data at Society for Immunotherapy of Cancer Annual Meeting and AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
2019-11-05,Rubius Therapeutics to Announce Third Quarter 2019 Financial Results
2019-11-04,Entrada Therapeutics Appoints Nathan Dowden as Chief Operating Officer
2019-10-28,"Should You Buy Rubius Therapeutics, Inc. (RUBY)?"
2019-10-17,Rubius Therapeutics Announces Oncology Poster Presentations at Upcoming Medical Conferences
2019-09-03,Rubius Therapeutics to Participate in 17th Annual Morgan Stanley Global Healthcare Conference
2019-08-13,Rubius Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress
2019-08-07,Rubius Therapeutics to Announce Second Quarter 2019 Financial Results
2019-07-25,Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy
2019-07-19,Investors Who Bought Rubius Therapeutics (NASDAQ:RUBY) Shares A Year Ago Are Now Down 44%
2019-06-05,Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs
2019-05-28,Rubius Therapeutics to Present at Jefferies 2019 Healthcare Conference
2019-05-23,Preclinical biotech Stoke Therapeutics plans $86M IPO
2019-05-15,Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress
2019-05-08,"In slow year for life science IPOs, this venture firm is making big money"
2019-05-06,Rubius Therapeutics to Announce First Quarter 2019 Financial Results
2019-04-03,Rubius Therapeutics to Participate in Jefferies 6th Annual IO Cell Therapy Summit
2019-04-02,Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting
2019-03-28,Rubius Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results with Business Updates
2019-03-25,"How Many Insiders Bought Rubius Therapeutics, Inc. (NASDAQ:RUBY) Shares?"
2019-03-25,Rubius Therapeutics Appoints Natalie Holles to its Board of Directors and Greg Whitehead as Senior Vice President and Chief Quality Officer
2019-03-19,Rubius Therapeutics to Announce Fourth Quarter and Full-Year 2018 Financial Results
2019-03-11,"Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria"
2019-02-27,Rubius Therapeutics Announces Poster Presentations at the 2019 American Association for Cancer Research Annual Meeting
2019-02-19,Rubius Therapeutics to Participate at Upcoming Investor Conferences
2019-01-07,Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference
2018-12-27,Rubius Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
2018-12-21,"Rubius Therapeutics, Inc. Secures $75 Million Loan Facility"
2018-12-17,Rubius Therapeutics Added to Nasdaq Biotechnology Index
2018-12-16,Qatar Fund Building Venture Capital Unit for U.S. Startups
2018-12-06,Cambridge's Moderna sets record with $604M IPO
2018-11-19,Rubius Therapeutics to Present at Evercore ISI HealthCONx Conference
2018-11-13,Rubius Therapeutics Reports Third Quarter 2018 Financial Results and Operational Progress
2018-11-06,Rubius Therapeutics to Participate in Jefferies London Healthcare Conference
2018-11-05,Rubius Therapeutics to Announce Third Quarter 2018 Financial Results
2018-09-24,Biotech Market is Rolling and These Companies Need to Be on Your Radar
2018-09-24,Rubius (RUBY) in Focus: Stock Moves 8.7% Higher
2018-09-20,Rubius Therapeutics to Participate in the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
2018-09-14,Rubius Therapeutics Added to Russell 2000 and 3000 Indexes
2018-09-05,How This Biotech IPO Is Facing Off Vs. BioMarin In Metabolic Disease
2018-09-04,Rubius Therapeutics to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference
2018-09-04,What you missed on your summer vacation in Mass. biotech news
2018-08-31,Rubius Therapeutics Reports Second Quarter 2018 Financial Results
2018-08-21,Rubius Therapeutics to Announce Second Quarter 2018 Financial Results
2018-07-25,"Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics"
2018-07-24,[$$] Gormley's Take: Public Markets' Embrace of Health Care Extends Beyond Biotech
2018-07-23,Rubius Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2018-07-20,[$$] Gormley's Take: Biotech Would-Be Acquirers Are Wary Buyers
2018-07-18,Rubius Therapeutics shares surge 35% in trading debut
2018-07-17,Rubius Therapeutics Announces Pricing of Initial Public Offering
